A detailed history of Vicus Capital transactions in Pfizer Inc stock. As of the latest transaction made, Vicus Capital holds 7,407 shares of PFE stock, worth $197,840. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,407
Previous 8,207 9.75%
Holding current value
$197,840
Previous $229,000 6.55%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $22,160 - $25,112
-800 Reduced 9.75%
7,407 $214,000
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $6,567 - $7,696
-260 Reduced 3.07%
8,207 $229,000
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $10,614 - $12,189
-410 Reduced 4.62%
8,467 $234,000
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $129,082 - $167,663
-4,940 Reduced 35.75%
8,877 $255,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $33,341 - $38,972
1,039 Added 8.13%
13,817 $458,000
Q2 2023

Aug 17, 2023

SELL
$36.12 - $41.79 $42,152 - $48,768
-1,167 Reduced 8.37%
12,778 $468,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $5,711 - $7,435
-145 Reduced 1.03%
13,945 $568,000
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $91,599 - $119,573
-2,194 Reduced 13.47%
14,090 $722,000
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $38,290 - $46,742
-875 Reduced 5.1%
16,284 $713,000
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $21,217 - $25,157
456 Added 2.73%
17,159 $900,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $63,592 - $78,799
-1,390 Reduced 7.68%
16,703 $865,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $747,602 - $1.11 Million
18,093 New
18,093 $956,000
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $894,123 - $1.01 Million
-24,899 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $157,235 - $177,330
-4,695 Reduced 15.86%
24,899 $902,000
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $40,164 - $51,072
-1,200 Reduced 3.9%
29,594 $1.09 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $91,535 - $107,391
-2,883 Reduced 8.56%
30,794 $1.13 Million
Q2 2020

Aug 03, 2020

BUY
$30.12 - $36.54 $34,005 - $41,253
1,129 Added 3.47%
33,677 $1.1 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $7,946 - $11,354
294 Added 0.91%
32,548 $1.06 Million
Q4 2019

Feb 04, 2020

SELL
$32.92 - $37.36 $36,376 - $41,282
-1,105 Reduced 3.31%
32,254 $1.26 Million
Q3 2019

Nov 18, 2019

SELL
$32.49 - $42.13 $85,091 - $110,338
-2,619 Reduced 7.28%
33,359 $1.2 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $99,180 - $111,356
-2,682 Reduced 6.94%
35,978 $1.56 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $114,375 - $125,660
-3,050 Reduced 7.31%
38,660 $1.64 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $21,697 - $24,737
-564 Reduced 1.33%
41,710 $1.82 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $47,568 - $57,697
1,380 Added 3.37%
42,274 $1.86 Million
Q2 2018

Aug 02, 2018

BUY
$32.98 - $35.16 $238,643 - $254,417
7,236 Added 21.5%
40,894 $1.48 Million
Q1 2018

May 07, 2018

BUY
$31.91 - $37.02 $324,907 - $376,937
10,182 Added 43.37%
33,658 $1.2 Million
Q4 2017

Jan 25, 2018

BUY
$33.26 - $35.29 $169,559 - $179,908
5,098 Added 27.74%
23,476 $850,000
Q3 2017

Oct 27, 2017

BUY
$31.0 - $34.15 $569,718 - $627,608
18,378
18,378 $656,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vicus Capital Portfolio

Follow Vicus Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.